Iro organization

Medidata Expands and Strengthens Decentralized Clinical Trials (DCT) Capabilities Through Groundbreaking Partnership with Circuit Clinical

NEW YORK–(BUSINESS WIRE)–Medidataa Dassault Systèmes company, today announced a unique and exclusive partnership with Circuit Clinical, an Integrated Research Organization (IRO). clinical circuit has created a network representing more than 90 physicians, across more than 30 sites, and a nationally accredited cancer center with a database of more than 2.5 million participants likely to qualify for clinical trials. Through Medidata’s strategic investment in Circuit Clinical’s $27 million Series C funding, Circuit Clinical will expand its decentralized clinical trials (DCT) network to 500 physician investigators and 15 million patients and help deliver the clinical research as a care option for more people in need.

All of Circuit Clinical’s sites will be standardized on Medidata’s RAVE and myMedidata technology solutions, making the company’s combined offerings a perfect turnkey option for customers interested in managing large, decentralized study programs. Medidata is the first company to offer a secure, unified, end-to-end platform for DCTs.

“This partnership represents a category-defining approach to provide sponsors and patients with a unified platform for all DCT needs and will improve patient access, inclusion and experience in clinical trials while accelerating timelines for sponsors and CROs,” said Kelly McKee, vice president of patient registries and recruitment at Medidata. “Working with Circuit Clinical further expands Medidata’s capabilities in the DCT space by collaborating with a market-leading integrated research organization focused on optimizing retention, reducing patient load, and identifying and creating of the best performing sites.

Circuit Clinical’s offering spans 10 therapy areas, including cardiovascular disease, diabetes, women’s health, kidney disease, digestive disease, rheumatoid arthritis, cancer, COVID-19 and others. Individuals from participating Circuit Clinical healthcare systems will be invited to join myMedidata clinical trial patient registries, providing better knowledge and access to clinical trial opportunities, as well as ongoing support and engagement in and out of a trial. Additionally, patients will have the ability to provide ratings and reviews of their clinical trial experiences through Circuit Clinical’s award-winning TrialJourney system.

A better overall study experience makes it easier for patients to stay enrolled in trials and accelerate turnaround times, reducing overall costs for sites and sponsors. With study participants in mind, Medidata’s Patient Cloud solutions were developed using the company’s award-winning technology Patient-centered by design to treat. This infuses the patient perspective into the software development lifecycle to create technical solutions that enhance the overall patient experience in clinical research interactions. These are the main reasons why 10 of the top 12 pharmaceutical companies and 8 of the top 10 CROs use Medidata DCT solutions.

“We look forward to innovating with Medidata in the emerging DCT market and making a real difference in the lives of patients,” said Irfan Khan, MD, CEO of Circuit Clinical. “The combined capabilities of Circuit Clinical’s and Medidata’s software solutions will enhance the ability to deliver hybrid or fully decentralized trials through Circuit Clinical’s networked health systems and patient engagement capabilities. We look forward to welcoming Medidata to our Board of Directors as an observer.

Medidata is a wholly-owned subsidiary of Dassault Systèmes which, with its 3DEXPERIENCE platform, is positioned to lead the digital transformation of life sciences in the era of personalized medicine with the first end-to-end scientific and commercial platform, from marketing research.

About Medidata

Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate evidence and insights to help pharmaceutical, biotechnology, medical device, and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users from more than 1,900 customers and partners access the world’s most trusted platform for clinical development, commercial data, and real-world data. Medidata, a Dassault Systèmes company (Euronext Paris: FR0014003TT8, DSY.PA), is headquartered in New York and has offices around the world to serve its customers’ needs. Find out more about www.medidata.com and follow us @medidata.

About Dassault Systemes

Dassault Systèmes, the 3DEXPERIENCE company, is a catalyst for human progress. We provide companies and individuals with collaborative 3D virtual environments to imagine sustainable innovations. By creating real-world virtual twin experiences with our 3DEXPERIENCE platform and applications, our customers are pushing the boundaries of innovation, learning and production. Dassault Systèmes brings value to more than 290,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit www.3ds.com.

3DEXPERIENCE, the Compass icon, the 3DS logo, CATIA, BIOVIA, GEOVIA, SOLIDWORKS, 3DVIA, ENOVIA, NETVIBES, MEDIDATA, CENTRIC PLM, 3DEXCITE, SIMULIA, DELMIA and IFWE are trademarks or registered trademarks of Dassault Systèmes, a “European Company” (RCS de Versailles n° B 322 306 440), or its subsidiaries in the United States and/or in other countries.

About Clinical Circuit

clinical circuit, one of the largest integrated research organizations in the United States, is dedicated to empowering patients to choose clinical research as a care option. Circuit Clinical® is committed to transforming the way physicians and their patients find, choose and participate in clinical research. They provide clinical research services and an award-winning patient engagement platform, trialjourney.com. Follow Circuit Clinical on Facebook, LinkedIn, instagramand Twitter.